Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
alnylam pharmaceuticals
5
×
boston blog main
clinical trials
life sciences
national blog main
rna interference
boston
boston top stories
drugs
fda
patisiran
aminolevulinic acid
biotech
givosiran
hereditary transthyretin amyloidosis
national top stories
new york blog main
new york top stories
onpattro
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
akcea therapeutics
akin akinc
alexion pharmaceuticals
alirocumab
amgen
andrew fire
boehringer ingelheim
craig mello
deals
dicerna pharamceuticals
evercore isi
evolocumab
heart attack
hepatitis b
hepatitis b virus
inclisiran
inotersen
john maraganore
What
drug
pharmaceuticals
5
×
alnylam
medicine
rna
rnai
data
fda
interference
medicines
new
ok
second
seek
speedy
afternoon
ago
alnylam’s
approval
approved
based
caught
causing
cholesterol
cleared
dicerna
disease
evidence
eye
far
gene
gets
heart
hepatitis
history
indicated
intended
landmark
lasting
long
Language
unset
Current search:
pharmaceuticals
×
photo
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug